Mercer Global Advisors »

Protalix Biotherapeutics shares owned by Mercer Global Advisors

Quarter-by-quarter ownership of Protalix Biotherapeutics (PLX) shares owned by Mercer Global Advisors from 13F filings

Historical chart of Mercer Global Advisors investment in Protalix Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Protalix Biotherapeutics held by Mercer Global Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Protalix Biotherapeutics by Mercer Global Advisors

Quarter filed Position value Share count Share price at filing
2026-06-30 $20k 8.6k 2.33

More positions owned by Mercer Global Advisors

Ishares Tr Core Us Aggbd Et (AGG)
Vanguard Bd Index Fds Short Trm Bond (BSV)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Dimensional Etf Trust Us Cor Equ 2 Etf (DFAC)
Ishares Tr Msci Usa Mmentm (MTUM)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Dimensional Etf Trust Us Mktwide Value (DFUV)
Dimensional Etf Trust Us High Prof Etf (DUHP)
Vanguard Charlotte Fds Total Int Bd Etf (BNDX)
Dimensional Etf Trust Intl Core Equity (DFIC)
Ishares Tr Msci Intl Moment (IMTM)
Dimensional Etf Trust Internatnal Val (DFIV)
Dimensional Etf Trust Intl High Profit (DIHP)
American Centy Etf Tr Avan Us Smal Etf (AVSC)
Ishares Tr National Mun Etf (MUB)

View all positions for Mercer Global Advisors

Top funds holding Protalix Biotherapeutics

BlackRock
Renaissance Technologies
Geode Capital Management
State Street Corporation
Northern Trust
Vanguard Portfolio Management
Stratos Wealth Partners
Dimensional Fund Advisors
Goldman Sachs Group
Marshall Wace
Citadel Advisors
Susquehanna International
Morgan Stanley
OTR - Nominee Name for The State Teachers Retirement Board of Ohio
Bank of New York Mellon

View all funds holding Protalix Biotherapeutics